GAM
MRNA icon

Groupama Asset Management’s Moderna MRNA Stock Holding History

Groupama Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,838
Closed -$1.17M – 472
2024
Q3 		$1.17M Buy
21,838
+4,920
+29% +$452K 0.03% 239
2024
Q2 		$2.01M Buy
16,918
+8,728
+107% +$1.1M 0.03% 209
2024
Q1 		$3.07M Sell
8,190
-20,783
-72% -$2.09M 0.06% 183
2023
Q4 		$2.88M Buy
+28,973
New +$2.44M 0.08% 168

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Groupama Asset Management's MRNA Position: Q4 2024 in Review

Groupama Asset Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 21,838 shares — an estimated $1.17M sold.

Groupama Asset Management first reported a position in MRNA in Q4 2023 and held it in 4 quarters. The position peaked at $3.07M in Q1 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Groupama Asset Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Groupama Asset Management sold 21,838 Moderna shares in Q4 2024, an estimated $1.17M.
  • Groupama Asset Management first reported a position in Moderna in Q4 2023 and held it in 4 quarters.
  • Groupama Asset Management's Moderna position peaked at $3.07M in Q1 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Groupama Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.